March 21, 2023

The Indie Toaster

Complete News World

‘You are not a horse’

The U.S. Food and Drug Administration (FDA) today mocked the use of Ivermectin for the treatment of Govit-19. In Brazil, The drug is protected by President Jair Bolzano (non-party)It discredits vaccines, but supports early treatment.

In a post posted on social media, the company says: “You’re not a horse. You’re not a cow. Seriously, guys. Stop.” Like Anvisa (National Institutes of Health), the FDA has a role to play in reviewing and publishing the use of drugs and vaccines in the United States.

The FDA says it has filed numerous reports of patients being hospitalized after self-medication with ivermectin, a drug used in the United States to treat or prevent parasites in patients and animals seeking medical help.

The company warns that “the use of any treatment for Covit-19 that is not FDA approved or approved is extremely dangerous and can cause serious harm.”

In the United States, there is a growing anti-vaccine movement that questions the safety of vaccines. Research suggests that resistance to the vaccine follows political divisions, Nearly 30% of Republicans said they would not be vaccinated, Compared to just 4% of Democrats.

The FDA insists that ivermectin is not an antiviral, that is, a drug that does not treat viruses. In the United States, certain doses are approved to treat parasitic worms in humans, such as lice. There is only initial research to be done on the analysis of Ivermectin and Govit.

“Taking too much of this drug can be dangerous and cause serious harm,” he warns. Even for approved use, Ivermectin can react with other medications such as anticoagulants, causing overdose, seizures, coma and even death.

See also  'Little Nugget' Born in McDonald's Bathroom; Watch the story

There is a lot of misinformation and you may have heard that the use of large doses of Ivermectin is okay. This is wrong. “
Excerpt from a text published by the FDA

According to the FDA, the production of ivermectin in animals and humans is different. “For one thing, veterinary drugs are often used on larger animals, such as horses or cows, which weigh more than us – a ton or more. Such high doses can be highly toxic to humans.”


Bolzano defends medicine

In July, President Bolzano Kovid again defended the use of Ivermectin for treatment. During his weekly session, the President cited an article prepared by ten researchers from various universities in the United Kingdom, of which eight were peer-reviewed research, nine were not reviewed, six were not even published and one was an independent publication.

Precisely because they have not yet mastered the study of peers, non-reviewed studies are not conclusive and are generally not used to support public policy.

Ivermectina Govt reduces mortality by 56%, study from Oxford University shows. Sooner or later, the use of Ivermectin will be scientifically proven.
President Bolzano defends the use of ineffective drugs against Govt

The use of Ivermectin reduces mortality by 56% from covit-19, which is 11 out of 24 studies, and research has not clarified whether the articles citing this percentage have been reviewed or not.

In a direct study, he said that the reduction in the percentage of deaths cited in the study would be an “indication” that half of the more than 500,000 deaths by Covid-19 in Brazil could have been avoided if it had been called “early treatment”. “Not politicized”.

See also  "Money doesn't make me happy"

However, given the ineffectiveness of the study approved by the authors, there is no way to support the President’s statement that the “initial treatment” recommended by Bolzano refers to drugs that have been shown to be ineffective for Govit-19.

Anvisa (National Institute of Health Monitoring), in a note released in July last year and updated in April, There are no definitive studies This demonstrates the use of Ivermect Corona virus.

The WHO (World Health Organization) recommends the use of drugs Only in clinical trials, The action of the drug is endless in Govit cases. European Pharmaceuticals Association (EMA), the regulatory body of the European Union, Advises against its use outside of clinical trials.